| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | SVP, Chief Business Officer
2 companies
Gregory Kathryn is a SVP, Chief Business Officer at Rein Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 20 buys and 0 sells.
Estimated insider holdings value: $59K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 6, 2024 | XAGE Longevity Health Holdings, Inc. | Director | Buy | 1,260 | $0.51 | $642.60 | +5.9% | - | - | |
| Aug 30, 2024 | XAGE Longevity Health Holdings, Inc. | Director | Buy | 109 | $0.57 | $62.13 | +0.5% | - | - | |
| Aug 29, 2024 | XAGE Longevity Health Holdings, Inc. | Director | Buy | 1,736 | $0.56 | $972.16 | +4.4% | - | - | |
| Aug 27, 2024 | XAGE Longevity Health Holdings, Inc. | Director | Buy | 2,413 | $0.71 | $1,713.23 | +14.2% | - | - | |
| Aug 26, 2024 | XAGE Longevity Health Holdings, Inc. | Director | Buy | 4,826 | $0.72 | $3,474.72 | +18.1% | - | - | |
| Aug 22, 2024 | XAGE Longevity Health Holdings, Inc. | Director | Buy | 5,429 | $0.76 | $4,126.03 | +33.0% | - | - | |
| Dec 15, 2023 | XAGE Longevity Health Holdings, Inc. | Director | Buy | 1,130 | $3.82 | $4,320.29 | +9.8% | - | - | |
| Dec 13, 2023 | XAGE Longevity Health Holdings, Inc. | Director | Buy | 3,261 | $4.20 | $13,696.20 | +31.8% | - | - | |
| Dec 8, 2023 | XAGE Longevity Health Holdings, Inc. | Director | Buy | 2,336 | $3.03 | $7,085.85 | +34.1% | - | - | |
| Aug 13, 2019 | RNTX Rein Therapeutics, Inc. | SVP, Chief Business Officer | Buy | 45,000 | $0.65 | $29,025.00 | New | - | - |